These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 15607931

  • 1. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
    Chaney SG, Campbell SL, Bassett E, Wu Y.
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
    [Abstract] [Full Text] [Related]

  • 2. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG.
    Biochemistry; 2003 Dec 09; 42(48):14197-206. PubMed ID: 14640687
    [Abstract] [Full Text] [Related]

  • 3. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M.
    J Inorg Biochem; 2004 Oct 09; 98(10):1551-9. PubMed ID: 15458816
    [Abstract] [Full Text] [Related]

  • 4. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
    Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, Chaney SG.
    Biochemistry; 1999 Aug 24; 38(34):11026-39. PubMed ID: 10460158
    [Abstract] [Full Text] [Related]

  • 5. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
    Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M.
    Cancer Res; 2004 Sep 15; 64(18):6469-75. PubMed ID: 15374956
    [Abstract] [Full Text] [Related]

  • 6. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
    Vaisman A, Masutani C, Hanaoka F, Chaney SG.
    Biochemistry; 2000 Apr 25; 39(16):4575-80. PubMed ID: 10769112
    [Abstract] [Full Text] [Related]

  • 7. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S, Masutani C, Hanaoka F, Iwai S, Kuraoka I.
    Carcinogenesis; 2010 Mar 25; 31(3):388-93. PubMed ID: 20015866
    [Abstract] [Full Text] [Related]

  • 8. NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.
    Wu Y, Pradhan P, Havener J, Boysen G, Swenberg JA, Campbell SL, Chaney SG.
    J Mol Biol; 2004 Aug 27; 341(5):1251-69. PubMed ID: 15321720
    [Abstract] [Full Text] [Related]

  • 9. Specificity of platinum-DNA adduct repair.
    Chaney SG, Vaisman A.
    J Inorg Biochem; 1999 Oct 27; 77(1-2):71-81. PubMed ID: 10626357
    [Abstract] [Full Text] [Related]

  • 10. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
    Wu Y, Bhattacharyya D, King CL, Baskerville-Abraham I, Huh SH, Boysen G, Swenberg JA, Temple B, Campbell SL, Chaney SG.
    Biochemistry; 2007 Jun 05; 46(22):6477-87. PubMed ID: 17497831
    [Abstract] [Full Text] [Related]

  • 11. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
    Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG.
    Biochemistry; 2003 Feb 18; 42(6):1777-88. PubMed ID: 12578393
    [Abstract] [Full Text] [Related]

  • 12. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
    Bassett E, Vaisman A, Tropea KA, McCall CM, Masutani C, Hanaoka F, Chaney SG.
    DNA Repair (Amst); 2002 Dec 05; 1(12):1003-16. PubMed ID: 12531010
    [Abstract] [Full Text] [Related]

  • 13. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
    Vaisman A, Chaney SG.
    J Biol Chem; 2000 Apr 28; 275(17):13017-25. PubMed ID: 10777605
    [Abstract] [Full Text] [Related]

  • 14. Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics.
    Sharma S, Gong P, Temple B, Bhattacharyya D, Dokholyan NV, Chaney SG.
    J Mol Biol; 2007 Nov 09; 373(5):1123-40. PubMed ID: 17900616
    [Abstract] [Full Text] [Related]

  • 15. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin.
    Scheeff ED, Briggs JM, Howell SB.
    Mol Pharmacol; 1999 Sep 09; 56(3):633-43. PubMed ID: 10462551
    [Abstract] [Full Text] [Related]

  • 16. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
    Alt A, Lammens K, Chiocchini C, Lammens A, Pieck JC, Kuch D, Hopfner KP, Carell T.
    Science; 2007 Nov 09; 318(5852):967-70. PubMed ID: 17991862
    [Abstract] [Full Text] [Related]

  • 17. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta.
    Choi JY, Guengerich FP.
    J Mol Biol; 2005 Sep 09; 352(1):72-90. PubMed ID: 16061253
    [Abstract] [Full Text] [Related]

  • 18. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
    Ahmad S.
    Chem Biodivers; 2010 Mar 09; 7(3):543-66. PubMed ID: 20232326
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin: mechanism of action and antineoplastic activity.
    Raymond E, Faivre S, Woynarowski JM, Chaney SG.
    Semin Oncol; 1998 Apr 09; 25(2 Suppl 5):4-12. PubMed ID: 9609103
    [Abstract] [Full Text] [Related]

  • 20. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
    Suzuki N, Yasui M, Santosh Laxmi YR, Ohmori H, Hanaoka F, Shibutani S.
    Biochemistry; 2004 Sep 07; 43(35):11312-20. PubMed ID: 15366941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.